The grey market premium (GMP) also points to a sharp difference in listing expectations. Jio Platforms' IPO GMP stood at ₹250, implying a potential listing gain of around 22.34% over the upper end of its price band, while Paras Healthcare's GMP was ₹12, indicating a potential gain of 1.73%. Grey market premiums are unofficial indicators and do not guarantee listing performance.
The public issues opened on 21 October and conclude on 23 October, with allotment scheduled for tomorrow (26 October).
Here's a closer look at the subscription figures, investor categories and latest GMP trends for both IPOs.
Reliance Industries-backed Jio Platforms' IPO closed with bids for 22.19 times the shares on offer, as total demand across the public issue and anchor investor placement crossed ₹7.4 lakh crore. The offering also received nearly 1.39 crore applications, marking an unprecedented response to the digital services company.
By 7 PM on Friday, investors had bid for 438.3 crore shares against 19.75 crore shares on offer, according to exchange data. Bids for the public issue alone exceeded ₹4.9 lakh crore, excluding the anchor book, while retail demand crossed ₹25,867 crore.